Business
Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day
Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business segments, and its long-range plan (LRP) to drive growth and value creation.
About this update from Solventum Corporation
[{"type":"text","content":"Provides 2028 Targets for Revenue Growth, Margin Expansion, and Free Cash Flow","length":78,"tagName":"p","attribs":{}},{"type":"text","content":"ST. PAUL, Minn., March 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business segments, and its long-range plan (LRP) to drive growth and value creation.","length":253,"tagName":"p"},{"type":"image","alt":"Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC)","displaySize":"","headline":null,"caption":"Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/95d3b82885a66001cfb99d992f38785e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/jB7DxrFrJMVlFTnHly7PFQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/95d3b82885a66001cfb99d992f38785e","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2369614/Solventum_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""Solventum has tremendous potential, with attractive businesses, large and growing markets, and highly regarded brands. We have undertaken a significant transformation to unlock the potential of our Medical Surgical, Dental Solutions, and Health Information Systems businesses, positioning the company to drive accelerated growth and create shareholder value," said Bryan Hanson, Chief Executive Officer of Solventum.","length":427,"tagName":"p"},{"type":"text","content":""Solventum has entered 2025 as a more focused company with an improving innovation engine and a purpose-built leadership team committed to realizing our mission of enabling better, smarter, safer healthcare to improve lives. The recently announced sale of our Purification & Filtration (P&F) business is a major milestone and will allow us to accelerate our plans and deliver for customers and shareholders. Our long-range plan demonstrates the progress we made in the last year and reflects our confidence in our ability to accelerate sales growth, expand margins, deliver EPS growth, and improve free cash flow," Hanson concluded.","length":650,"tagName":"p"},{"type":"text","content":"Long-Range Plan and Financial TargetsSol...